Prospective, Digitized Dietary Intake Monitoring in Individuals Undergoing Cancer Therapy

Memorial Sloan Kettering Cancer Center1 site in 1 country150 target enrollmentMay 31, 2022

ConditionsReceiving Allogeneic Hematopoietic Cell Transplants

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Receiving Allogeneic Hematopoietic Cell Transplants
Sponsor: Memorial Sloan Kettering Cancer Center
Enrollment: 150
Locations: 1
Primary Endpoint: establish a prospective database
Status: Active, not recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to develop a secure method of collecting dietary and nutritional intake information from people with cancer. The researchers will use this information to learn more about how dietary information may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.

Registry

clinicaltrials.gov

Start Date

May 31, 2022

End Date

May 2026

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Memorial Sloan Kettering Cancer Center

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patient is receiving or planning to receive therapy for cancer.
•Patient (or caregiver) has sufficient English proficiency.

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

establish a prospective database

Time Frame: 2 years

of nutritional intake data from immunotherapy patients that can be paired with the fecal and blood biospecimens already being collected under other protocols (06-107, 16-834) for the purpose of conducting studying correlations between nutrition, gut microbiome, and clinical outcomes.